Avsar.
SG

Healthcare · Pharmaceuticals

Shree Ganesh Remedies Ltd (SGRL)

₹715.00

Mkt cap
₹896 Cr
P/E ratio
58.00
P/B
5.63
Div yield
0.00%
ROE
10.80%
ROCE
14.20%
EPS (TTM)
₹12.33
Book value
₹127
52W range
477–750
Sector
Healthcare

Price history

Previous close

Shree Ganesh Remedies is an Ankleshwar-based manufacturer of pharmaceutical/API intermediates and specialty and fine chemicals. It also provides custom synthesis and contract manufacturing for pharmaceutical, agrochemical, polymer, and electronics customers across more than 20 countries. [1] [2]

NSE SGRLBSE 540737
Health check
Mixed
ValuationExpensive
ProfitabilityAverage
GrowthHigh
TechnicalsNeutral
52-week range
−4.65% from high
₹715
₹477+49.88% from low₹750
Current
₹715.00
Prev close
₹690.00
Day
+3.62%
Price performance
1D
+3.62%
1W
+5.14%
1M
+4.52%
3M
—
6M
—
1Y
—
YTD
+33.15%

Financials

Revenue, profit & margin
P/E ratio
58.0×
SGRL is 68% above the sector median of 34.6×
SGRL58.0×
Sector median34.6×
 Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Trend
Sales26.7233.4227.9737.3324.7832.3327.0524.4324.6730.3221.1133.2014.36
Expenses20.1624.1919.7620.3916.6521.0217.1414.5517.3720.7014.3821.8211.01
Operating Profit6.569.238.2116.948.1311.319.919.887.309.626.7311.383.35
OPM %24.55%27.62%29.35%45.38%32.81%34.98%36.64%40.44%29.59%31.73%31.88%34.28%23.33%
Other Income0.730.801.111.320.540.190.712.290.660.690.661.020.94
Interest0.010.010.020.150.320.430.380.960.941.010.740.880.32
Depreciation1.021.411.881.862.022.422.702.422.422.592.672.802.44
Profit before tax6.268.617.4216.256.338.657.548.794.606.713.988.721.53
Tax %27.64%23.81%35.31%22.46%26.70%25.78%27.85%24.80%25.00%26.23%22.36%28.10%27.45%
Net Profit4.546.554.8012.594.656.425.436.603.454.963.106.271.12
EPS in Rs3.555.123.759.843.625.004.235.142.693.862.414.880.87
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

No reaction history yet.
No quarterly filings ingested yet.

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Jun 2026
72.83%Promoter
Promoters72.83%
FIIs0.00%
DIIs0.52%0.52
Public26.65%0.51
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,837.3034.904,40,8300.87%2,901+5.95%15,300+10.46%20.53%
Divi's Lab.₹9,375.0083.542,48,8770.32%902+65.50%3,080+27.80%21.97%
Torrent Pharma.₹4,840.0082.511,84,0980.79%566+5.79%4,921+54.85%15.19%
Zydus Lifesci.₹1,160.0023.771,15,7100.09%990−35.09%8,017+21.96%21.14%
Cipla₹1,394.5031.481,12,6560.93%786−39.19%7,119+2.33%15.49%
Laurus Labs₹1,954.0096.561,05,5770.10%362+125.49%2,026+29.10%17.76%
Aurobindo Pharma₹1,734.0026.3999,7710.23%1,032+28.11%9,150+16.30%12.86%
Shree Ganesh Rem₹697.7557.988960.00%1−67.54%14−41.79%14.16%
Median: 158 Co.₹433.9034.562,2050.08%13+29.57%164+18.57%14.96%

Filings

Annual reports10
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022Annual Report 2021Annual Report 2020Annual Report 2019Annual Report 2018Annual Report 2017
Concall transcripts18
PPTAug 2026TranscriptMay 2026PPTMay 2026PPTJan 2026TranscriptNov 2025PPTNov 2025RECNov 2025PPTAug 2025TranscriptMay 2025PPTMay 2025RECMay 2025PPTFeb 2025TranscriptNov 2024PPTNov 2024PPTAug 2024RECAug 2024PPTMay 2023PPTMar 2021
Announcements5
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 12 SepShareholder Meeting / Postal Ballot-Outcome of AGM 12 Sep - Shree Ganesh Remedies held its 31st AGM on September 12, 2026; approved financials and independent director appointment.Announcement under Regulation 30 (LODR)-Newspaper Publication 21 Aug - Newspaper Publication for Notice of Annual General MeetingReg. 34 (1) Annual Report. 20 AugAnnouncement under Regulation 30 (LODR)-Newspaper Publication 13 Aug